跳至主要内容
临床试验/NCT01960361
NCT01960361已完成4 期

A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of ICE Implant System Over 24 Months, for Patients With Tooth Loss Requiring up to 4 Implants, in Staged Loading Protocol

Alpha - Bio Tec Ltd.2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
35
试验地点
2
主要终点
Cumulative Survival Rate

研究概览

简要总结

The current prospective clinical study's aim is to determine ABT's ICE implant survival rate, crestal interproximal bone resorption during 24 months post implant insertion and to assimilate the drilling sequence during the clinical use of ICE implants.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women over the age of 18 years who need implantation of 1-4 implants.
  • Patients who are able to understand the requirements of the study, and are willing and able to comply with its instructions and schedules.
  • Patients who had provided written informed consent to participate in the study prior to any study procedure.
  • Patients in general good health in the opinion of the principal investigator as determined by medical history and oral examination.

排除标准

  • Immediate loaded implants.
  • Treatment with anticoagulant drugs (INR under 1.8) or bisphosphonates.
  • Treatment with anticonvulsants drugs.
  • Untreated Periodontal disease and inability of the patient to maintain reasonable oral hygiene according to study requirements.
  • Patients with history of alcohol, narcotics or drug abuse.
  • Patients under steroid therapy.
  • Patients receiving radiotherapy, chemotherapy or any other immunosuppressive treatment or who have been administered radiotherapy in the last 5 years.
  • Patients through at anytime received radiotherapy to the head and neck region will be excluded anyway.
  • Metabolic bone disorders and/or bone augmentation.
  • Uncontrolled bleeding disorders such as: hemophilia, thrombocytopenia, granulocytopenia.
  • Degenerative diseases.
  • Osteoradionecrosis.
  • Renal failure.
  • Organ transplant recipients.
  • HIV positive.
  • Malignant diseases.
  • Diseases that compromise the immune system.
  • Unbalanced diabetes mellitus. (HbA1c above 6.5)
  • Psychotic diseases.
  • Hypersensitivity to one of the components of the implant in general and titanium in particular.
  • Women who are pregnant or lactating.
  • Lack of patient cooperation.
  • Uncontrolled endocrine diseases.
  • Any systemic condition that is unbalanced and therefore precludes surgical procedures.
  • Parafunctional habits.- e.g Bruxism.
  • Temporomandibular joint disease.
  • Various pathologies of the oral mucosa for example: Benign mucous pemphigoid, desquamative ginigivitis, erosive lichen planus ,malignancy of oral cavity, bolus erosive diseases of the oral mucosa.

结局指标

主要结局

Cumulative Survival Rate

时间窗: 24 MONTHS

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验